EQT Dementia Fund is an EQT Life Sciences venture capital fund based in Luxembourg focused on companies developing products and technologies for dementia and neurodegenerative diseases. It backs early-stage life sciences, biotechnology, pharmaceuticals, HealthTech and medical device companies across Europe and the United States, with observed activity in Ireland. The fund has acted as a co-lead investor and typically invests €5 million to €25 million per company.